<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Prior distributions, scenarios and data sources • ModelTBBCGEngland</title>
<!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.3.1/jquery.min.js" integrity="sha256-FgpCb/KJQlLNfOu91ta32o/NMZxltwRo8QtmkMRdAu8=" crossorigin="anonymous"></script><!-- Bootstrap --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha256-916EbMg70RQy9LHiGkXzG8hSg9EdNy97GazNG/aiY1w=" crossorigin="anonymous">
<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha256-U5ZEeKfGNOja007MMD3YBI0A3OSZOQbeG6z2f2Y0hu8=" crossorigin="anonymous"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css" integrity="sha256-eZrrJcwDc/3uDhsdt61sL2oOBY362qM3lon1gyExkL0=" crossorigin="anonymous">
<!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.4/clipboard.min.js" integrity="sha256-FiZwavyI2V6+EXO1U+xzLG3IKldpiTFf3153ea9zikQ=" crossorigin="anonymous"></script><!-- sticky kit --><script src="https://cdnjs.cloudflare.com/ajax/libs/sticky-kit/1.1.3/sticky-kit.min.js" integrity="sha256-c4Rlo1ZozqTPE2RLuvbusY3+SU1pQaJC0TjuhygMipw=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script><meta property="og:title" content="Prior distributions, scenarios and data sources">
<meta property="og:description" content="">
<meta name="twitter:card" content="summary">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body>
    <div class="container template-article">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">ModelTBBCGEngland</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Released version">0.1.0</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
<li>
  <a href="../index.html">
    <span class="fa fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Articles
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
<li>
      <a href="../articles/future_scenarios.html">Future scenarios</a>
    </li>
    <li>
      <a href="../articles/model_report.html">Model report</a>
    </li>
    <li>
      <a href="../articles/prior_distributions.html">Prior distributions, scenarios and data sources</a>
    </li>
  </ul>
</li>
      </ul>
<ul class="nav navbar-nav navbar-right">
<li>
  <a href="https://github.com/seabbs/ModelTBBCGEngland">
    <span class="fa fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
</div>
<!--/.nav-collapse -->
  </div>
<!--/.container -->
</div>
<!--/.navbar -->

      
      </header><script src="prior_distributions_files/kePrint-0.0.1/kePrint.js"></script><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header toc-ignore">
      <h1>Prior distributions, scenarios and data sources</h1>
                        <h4 class="author">Sam Abbott</h4>
            
            <h4 class="date">2019-07-31</h4>
      
      <small class="dont-index">Source: <a href="https://github.com/seabbs/ModelTBBCGEngland/blob/master/vignettes/prior_distributions.Rmd"><code>vignettes/prior_distributions.Rmd</code></a></small>
      <div class="hidden name"><code>prior_distributions.Rmd</code></div>

    </div>

    
    
<div id="disease-and-vaccination-parameters" class="section level2">
<h2 class="hasAnchor">
<a href="#disease-and-vaccination-parameters" class="anchor"></a>Disease and vaccination parameters</h2>
<table class="table table">
<caption style="font-size: initial !important;">
Dynamic disease model parameters, descriptions, prior distributions, units, method used to derive the prior distribution and the type (i.e data derived, literature, assumption). All data based parameters are included. P = pulmonary TB, E = extra-pulmonary TB, v = vaccinated, i = age at vaccination, <span class="math inline">\(\mathcal{U}\)</span> = Uniform, <span class="math inline">\(\mathcal{N}\)</span> = Normal
</caption>
<thead><tr>
<th style="text-align:left;">
Parameter
</th>
<th style="text-align:left;">
Description
</th>
<th style="text-align:left;">
Distribution
</th>
<th style="text-align:left;">
Units
</th>
<th style="text-align:left;">
Method
</th>
<th style="text-align:left;">
Type
</th>
</tr></thead>
<tbody>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(C_{\text{eff}}\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The assumed effective number of contacts per infectious TB case.
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\mathcal{N}(1, 1)\)</span> truncated to be greater than 0.
</td>
<td style="text-align:left;width: 1.5cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 6cm; ">
Estimated using a dynamic model of TB transmission in England which found an effective contact rate of 1 in 1990. A conservative interval has then been applied.
</td>
<td style="text-align:left;width: 1.5cm; ">
Vynnycky et al.
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(C^{\text{hist}}_{\text{eff}}\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The assumed historic effective number of contacts per infectious TB case.
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\mathcal{U}(C_{\text{eff}}, 20)\)</span>
</td>
<td style="text-align:left;width: 1.5cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 6cm; ">
Estimated using a dynamic model of TB transmission in England which found an effective contact rate of 1 in 1990 and 20 in 1901. A conservative interval has been chosen to represent the parameter uncertainty. It has been assumed that the historic contact rate is bounded below by the current contact rate.
</td>
<td style="text-align:left;width: 1.5cm; ">
Vynnycky et al.
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(C^{\text{half-life}}_{\text{eff}}\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
It is assumed that the historic effective contact rate decays from 1935 to 1980 with a half-life of C^{}_{}.
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\mathcal{N}(5, 5)\)</span> truncated to be greater than 0.
</td>
<td style="text-align:left;width: 1.5cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 6cm; ">
The prior distribution is informed by historic TB notifications.
</td>
<td style="text-align:left;width: 1.5cm; ">
Assumption
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\beta_{\text{young-adult}}\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
This parameter modifies the effective contact rate in scenarios when the transmission probability is modified for young adults (15-24).
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\mathcal{U}(0, 10)\)</span>
</td>
<td style="text-align:left;width: 1.5cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 6cm; ">
An uninformative prior has been used bounded above to restrict the transmission probability in young adults to be no greater than 10 times that in other age-groups.
</td>
<td style="text-align:left;width: 1.5cm; ">
Assumption
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\Upsilon\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The age-specific proportion of cases that have pulmonary TB
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\Upsilon_{0-14,15-59,60-89} = \mathcal{N}(0.629, 0.00101)\)</span>, <span class="math inline">\(\mathcal{N}(0.706, 0.00411)\)</span>, <span class="math inline">\(\mathcal{N}(0.750, 0.00569)\)</span>
</td>
<td style="text-align:left;width: 1.5cm; ">
Proportion
</td>
<td style="text-align:left;width: 6cm; ">
Estimated using the age-specific proportion of cases that had pulmonary TB in the ETS.
</td>
<td style="text-align:left;width: 1.5cm; ">
Derived from data
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\rho\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The age-specific proportion of pulmonary TB cases that are smear positive
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\rho_{0-14,15-59,60-89} = \mathcal{N}(0.302, 0.0189)\)</span>, <span class="math inline">\(\mathcal{N}(0.652, 0.00518)\)</span>, <span class="math inline">\(\mathcal{N}(0.536, 0.00845)\)</span>
</td>
<td style="text-align:left;width: 1.5cm; ">
Proportion
</td>
<td style="text-align:left;width: 6cm; ">
Estimated using the age-specific proportion of pulmonary TB cases that were smear postive in the ETS.
</td>
<td style="text-align:left;width: 1.5cm; ">
Derived from data
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(C\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
Matrix of contact rates between each age group
</td>
<td style="text-align:left;width: 6cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 1.5cm; ">
Non-unique yearly contacts.
</td>
<td style="text-align:left;width: 6cm; ">
For each parameter sample a contact matrix was bootstrapped from the POLYMOD survey data, standardised using the UK born population in 2005, and then averaged to provided a symmetric contact matrix.
</td>
<td style="text-align:left;width: 1.5cm; ">
Mossong et al.
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\iota(t)\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The age-specific number of non-UK born pulmonary TB cases in England each year
</td>
<td style="text-align:left;width: 6cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 1.5cm; ">
Cases
</td>
<td style="text-align:left;width: 6cm; ">
The number of pulmonary non-UK born cases for each year were extracted from the ETS and grouped by age.
</td>
<td style="text-align:left;width: 1.5cm; ">
Derived from data
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\iota_{\text{scale}}\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
Scaling parameter for the importation of non-UK born cases between 1960 and 2000.
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\mathcal{N}(0, 200)\)</span>
</td>
<td style="text-align:left;width: 1.5cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 6cm; ">
This largely uninformative prior range was chosen so that non-UK born scaling can vary between approximately linear to approximately constant.
</td>
<td style="text-align:left;width: 1.5cm; ">
Assumption
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(M\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The proportion of mixing between the UK born and non-UK born population.
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\mathcal{N}(1, 1)\)</span> truncated to be greater than 0
</td>
<td style="text-align:left;width: 1.5cm; ">
Proportion
</td>
<td style="text-align:left;width: 6cm; ">
Any degree of mixing is allowed as there is little data on which to base this estimate. Mixing greater than 1 is allowed as this is used to represent non-UK born cases being in some way more infectious than non-UK born cases.
</td>
<td style="text-align:left;width: 1.5cm; ">
Assumption
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(M_{\text{young-adult}}\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
This parameter modifies the non-UK born mixing rate in scenarios when <span class="math inline">\(M\)</span> is modified for young adults (15-24).
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\mathcal{U}(0, 10)\)</span>
</td>
<td style="text-align:left;width: 1.5cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 6cm; ">
An uninformative prior has been used bounded above to restrict non-UK born mixing in young adults to be no greater than 10 times that in other age-groups.
</td>
<td style="text-align:left;width: 1.5cm; ">
Assumption
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\chi\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
Age-specific protection from infection with TB due to BCG vaccination
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\chi^v_{i} = \mathcal{N}(0.185\)</span>, <span class="math inline">\(0.0536)\)</span>, where <span class="math inline">\(i\)</span> is the age group vaccinated.
</td>
<td style="text-align:left;width: 1.5cm; ">
Proportion
</td>
<td style="text-align:left;width: 6cm; ">
A meta-analysis of the protection from infection due to BCG vaccinatiion in children. It has been assumed that there is no reduction in protection in UK born adults.
</td>
<td style="text-align:left;width: 1.5cm; ">
Roy et al.
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\epsilon_H\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The age-specific rate of transition to active disease during high risk latent period.
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\epsilon_H^{0-4,5-14,15-89} = \mathcal{N}(0.00695, 0.00130)\)</span>, <span class="math inline">\(\mathcal{N}(0.0028, 0.000561)\)</span>, <span class="math inline">\(\mathcal{N}(0.000335, 0.0000893)\)</span>
</td>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(days^{-1}\)</span>
</td>
<td style="text-align:left;width: 6cm; ">
From fitting a similar model to contact data in Australia, and Holland. Distribution derived by the assumption of a normal distribution based on 95% credible intervals.
</td>
<td style="text-align:left;width: 1.5cm; ">
Ragonnet et al.
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\kappa\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The reciprocal of the age-specific average high risk latent period.
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\kappa^{0-4,5-14,15-89} = \mathcal{N}(0.0133, 0.00242)\)</span>, <span class="math inline">\(\mathcal{N}(0.0120, 0.00207)\)</span>, <span class="math inline">\(\mathcal{N}(0.00725, 0.00191)\)</span>
</td>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(days^{-1}\)</span>
</td>
<td style="text-align:left;width: 6cm; ">
From fitting a similar model to contact data in Australia, and Holland. Distribution derived by the assumption of a normal distribution based on 95% credible intervals.
</td>
<td style="text-align:left;width: 1.5cm; ">
Ragonnet et al.
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\epsilon_L\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The reciprocal of the age-specific average low risk latent period.
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\epsilon_L^{0-4,5-14,15-89} = \mathcal{N}(8.00e^{-6}, 4.08e^{-6})\)</span>, <span class="math inline">\(\mathcal{N}(9.84e^{-6}, 4.67e^{-6})\)</span>, <span class="math inline">\(\mathcal{N}(5.95e^{-6}, 2.07e^{-6})\)</span>
</td>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(days^{-1}\)</span>
</td>
<td style="text-align:left;width: 6cm; ">
From fitting a similar model to contact data in Australia, and Holland. Distribution derived by the assumption of a normal distribution based on 95% credible intervals.
</td>
<td style="text-align:left;width: 1.5cm; ">
Ragonnet et al.
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\epsilon^{\text{older-adult}}_L\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
This parameter modifies the activation rate of low risk latent cases who are 70+ and reduces the activaton rate for other adults so that the mean activation rate is <span class="math inline">\(\epsilon_L^{15-89}\)</span>
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\mathcal{N}(2, 0.5)\)</span> truncated to be at least 1.
</td>
<td style="text-align:left;width: 1.5cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 6cm; ">
Evidence suggests that activation risk increases when individuals enter old age. A largely uninformative prior has been used centred around an increase in risk of double the average rate.
</td>
<td style="text-align:left;width: 1.5cm; ">
Horsburgh, Jr. et al.
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\alpha_i^T\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The BCG vaccine effectiveness at preventing the development of active TB disease in a TB free population
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\alpha^T_{i,i+5,i+10,i+15,i+20,i+25} = 1 - e^{\alpha^{\text{ln}(T)}_{i,i+5,i+10,i+15,i+20,i+25}}\)</span>, where <span class="math inline">\(\alpha^{\text{ln}(T)}_{i,i+5,i+10,i+15,i+20,i+25} = \mathcal{N}(-1.86, 0.22)\)</span>, <span class="math inline">\(\mathcal{N}(-1.19, 0.24)\)</span>, <span class="math inline">\(\mathcal{N}(-0.84, 0.22)\)</span>, <span class="math inline">\(\mathcal{N}(-0.84, 0.2)\)</span>, <span class="math inline">\(\mathcal{N}(-0.28, 0.19)\)</span>, <span class="math inline">\(\mathcal{N}(-0.23, 0.29))\)</span> and <span class="math inline">\(i\)</span> is the age group vaccinated
</td>
<td style="text-align:left;width: 1.5cm; ">
Proportion
</td>
<td style="text-align:left;width: 6cm; ">
Poisson regression used to calculate Risk Ratios from literature values. A distribution is then found using the log normal approximation. Effectiveness estimates are caculated using 1 minus the exponentiated log normal distribution.
</td>
<td style="text-align:left;width: 1.5cm; ">
Hart et al. and Mangtani et al.
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\delta\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
Reduction in susceptibilty to infection for low risk latent cases.
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\mathcal{N}(0.78\)</span>, <span class="math inline">\(0.0408)\)</span>
</td>
<td style="text-align:left;width: 1.5cm; ">
Proportion
</td>
<td style="text-align:left;width: 6cm; ">
A review of prospective cohort studies of persons exposed to individuals with infectious tuberculosis that was published prior to the widespread treatment of latent tuberculosis.
</td>
<td style="text-align:left;width: 1.5cm; ">
Andrews et al.
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\nu^{P, E}\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The reciprocal of the average infectious period
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\nu^P_{(0-14,15-89)} = \mathcal{N}(0.181, 0.310)^{-1}\)</span>, <span class="math inline">\(\mathcal{N}(0.328, 0.447)^{-1}\)</span>, <span class="math inline">\(\nu^E_{(0-14, 15-89)} = \mathcal{N}(0.306, 0.602 )^{-1}\)</span>, <span class="math inline">\(\mathcal{N}(0.480, 0.866)^{-1}\)</span>
</td>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(years^{-1}\)</span>
</td>
<td style="text-align:left;width: 6cm; ">
Estimated based on the time from initial symptoms to starting treatment
</td>
<td style="text-align:left;width: 1.5cm; ">
Derived from data
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\phi\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
The reciprocal of the time to succesful treatment completion
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\phi_{0-14,15-69,70-89} = \mathcal{N}(0.606,0.237)^{-1}\)</span>, <span class="math inline">\(\mathcal{N}(0.645, 0.290)^{-1}\)</span>, <span class="math inline">\(\mathcal{N}(0.616, 0.265)^{-1}\)</span> and truncated to be greater than 4 months
</td>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(years^{-1}\)</span>
</td>
<td style="text-align:left;width: 6cm; ">
Estimated based on the time from starting treatment to treatment completion.
</td>
<td style="text-align:left;width: 1.5cm; ">
Derived from data
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\mu\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
Rate of age-specific pulmonary/extra-pulmonary TB TB mortality
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\mu_{0-14,15-59,60-89} = \mathcal{N}(0.0039, 0.018)\)</span>, <span class="math inline">\(\mathcal{N}(0.0226, 0.00787)\)</span>, <span class="math inline">\(\mathcal{N}(0.117, 0.0165)\)</span> truncated to be greater than 0.
</td>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(years^{-1}\)</span>
</td>
<td style="text-align:left;width: 6cm; ">
Estimated based on outcomes at 12 months where cause of death was known, including all-cause deaths in the denominator.
</td>
<td style="text-align:left;width: 1.5cm; ">
Derived from data
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\zeta\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
Rate of loss to follow up
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\zeta_{0-14,15-59,60-89} = \mathcal{N}(0.00976, 0.0179)\)</span>, <span class="math inline">\(\mathcal{N}(0.0304, 0.00764)\)</span>, <span class="math inline">\(\mathcal{N}(0.00614, 0.0159)\)</span>, truncated to be greater than 0.
</td>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(years^{-1}\)</span>
</td>
<td style="text-align:left;width: 6cm; ">
Estimated based on outcomes at 12 months for TB cases
</td>
<td style="text-align:left;width: 1.5cm; ">
Derived from data
</td>
</tr>
</tbody>
</table>
</div>
<div id="demographic-model-parameters" class="section level2">
<h2 class="hasAnchor">
<a href="#demographic-model-parameters" class="anchor"></a>Demographic model parameters</h2>
<table class="table table">
<caption style="font-size: initial !important;">
Demographic model parameters, descriptions, prior distributions, units, method used to derive the prior distribution and the type (i.e data derived, literature, assumption). <span class="math inline">\(\mathcal{U}\)</span> = Uniform and i = age at vaccination.
</caption>
<thead><tr>
<th style="text-align:left;">
Parameter
</th>
<th style="text-align:left;">
Description
</th>
<th style="text-align:left;">
Distribution
</th>
<th style="text-align:left;">
Units
</th>
<th style="text-align:left;">
Method
</th>
<th style="text-align:left;">
Type
</th>
</tr></thead>
<tbody>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\omega(t)\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
Time varying births
</td>
<td style="text-align:left;width: 6cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 1.5cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 6cm; ">
The dataset contains the estimated number of births from 1929-2015 in England. From 2016 onwards the numbers of births are projections as published by ONS.
</td>
<td style="text-align:left;width: 1.5cm; ">
Derived from data
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\gamma\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
BCG vaccination coverage
</td>
<td style="text-align:left;width: 6cm; ">
<span class="math inline">\(\gamma_{i} = \mathcal{N}(0.75, 0.05)\)</span> Where <span class="math inline">\(i\)</span> is the age group vaccinated.
</td>
<td style="text-align:left;width: 1.5cm; ">
Proportion
</td>
<td style="text-align:left;width: 6cm; ">
England has a robust national health service and an established system for providing BCG vaccination.
</td>
<td style="text-align:left;width: 1.5cm; ">
Assumption
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\theta\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
Rate of ageing
</td>
<td style="text-align:left;width: 6cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(years^{-1}\)</span>
</td>
<td style="text-align:left;width: 6cm; ">
Defined as the reciprocal of the width of the modelled age groups.
</td>
<td style="text-align:left;width: 1.5cm; ">
Model defined
</td>
</tr>
<tr>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(\mu^{\text{all-cause}}(t)\)</span>
</td>
<td style="text-align:left;width: 4cm; ">
Time varying all-cause age-specific mortality rate
</td>
<td style="text-align:left;width: 6cm; ">
<ul><li></ul>
</td>
<td style="text-align:left;width: 1.5cm; ">
<span class="math inline">\(years^{-1}\)</span>
</td>
<td style="text-align:left;width: 6cm; ">
Age specific mortality averaged across age group from 1981-2015. From 2016 onwards, and prior to 1981, mortality rates are modelled using a exponential model fit to data from 1981 until 2015.
</td>
<td style="text-align:left;width: 1.5cm; ">
Derived from data
</td>
</tr>
</tbody>
</table>
</div>
<div id="data-sources" class="section level2">
<h2 class="hasAnchor">
<a href="#data-sources" class="anchor"></a>Data sources</h2>
<table class="table">
<caption>Sources used to parameterise the disease and demographic models. Parameters that use the source are given, as well as the study type, setting, year/years studied and a description of the study/data source.</caption>
<colgroup>
<col width="24%">
<col width="11%">
<col width="8%">
<col width="8%">
<col width="32%">
<col width="13%">
</colgroup>
<thead><tr class="header">
<th align="center">Parameters</th>
<th align="center">Study Type</th>
<th align="center">Setting</th>
<th align="center">Year</th>
<th align="center">Description</th>
<th align="center">Source</th>
</tr></thead>
<tbody>
<tr class="odd">
<td align="center">
<span class="math inline">\(\iota(t)\)</span>, <span class="math inline">\(\mu\)</span>, <span class="math inline">\(\nu^{P, E}\)</span>, <span class="math inline">\(\phi\)</span>, <span class="math inline">\(\rho\)</span>, <span class="math inline">\(\Upsilon\)</span>, <span class="math inline">\(\zeta\)</span>
</td>
<td align="center">-</td>
<td align="center">England</td>
<td align="center">2000-2015</td>
<td align="center">The Enhanced Tuberculosis Surveillance System (ETS) is a robust national data collection system that collects demographic and microbiological data on all notified cases in England.</td>
<td align="center">ETS</td>
</tr>
<tr class="even">
<td align="center">
<span class="math inline">\(\mu^{\text{all-cause}}(t)\)</span>, <span class="math inline">\(\omega(t)\)</span>
</td>
<td align="center">-</td>
<td align="center">England</td>
<td align="center">-</td>
<td align="center">The Office for National Statistics (ONS) compiles demographic, health, enconomic, and social data for the United Kingdom</td>
<td align="center">ONS</td>
</tr>
<tr class="odd">
<td align="center">
<span class="math inline">\(C_{\text{eff}}\)</span>, <span class="math inline">\(C^{\text{hist}}_{\text{eff}}\)</span>
</td>
<td align="center">Dynamic modelling study</td>
<td align="center">England</td>
<td align="center">Up to 1990</td>
<td align="center">Used a dynamic model of tuberculosis, robustly parameterised to the available evidence and including realistic population demographis to estimate the effective contact rate of TB over time until the 1990’s in the UK born white male population.</td>
<td align="center"><span class="citation">[@Vynnycky1999]</span></td>
</tr>
<tr class="even">
<td align="center"><span class="math inline">\(C\)</span></td>
<td align="center">Contact survey</td>
<td align="center">Europe - including the United Kingdom</td>
<td align="center">2005</td>
<td align="center">Conducted contact surveys, based on a contact diary, in multiple European countries. Contacts were stratified by age and type of contact. In the United Kingdom over a thousand people were surveyed.</td>
<td align="center"><span class="citation">[@Mossong2008]</span></td>
</tr>
<tr class="odd">
<td align="center"><span class="math inline">\(\chi\)</span></td>
<td align="center">Systematic review and meta-analysis</td>
<td align="center">Global</td>
<td align="center">Up to 2014</td>
<td align="center">A meta-analysis; conducted with the aim of determining whether BCG vaccination protects against Mycobacterium tuberculosis infection as assessed by interferon <span class="math inline">\(\gamma\)</span> release assays (IGRA) in children. Estimated both protection from initial latent infection and active TB disease.</td>
<td align="center"><span class="citation">[@Roy2014]</span></td>
</tr>
<tr class="even">
<td align="center">
<span class="math inline">\(\epsilon_H\)</span>, <span class="math inline">\(\epsilon_L\)</span>, <span class="math inline">\(\kappa\)</span>
</td>
<td align="center">Systematic review</td>
<td align="center">Global</td>
<td align="center">Up to 2017</td>
<td align="center">Aimed to determine which dynamic TB model structure best captured the observed activation dynamics of TB. Identified 6 different commonly used model structures and compared them by fitting to activation data from the Netherlands and Australia.</td>
<td align="center"><span class="citation">[@Ragonnet2017]</span></td>
</tr>
<tr class="odd">
<td align="center"><span class="math inline">\(\alpha_i^T\)</span></td>
<td align="center">Clinical trial</td>
<td align="center">England</td>
<td align="center">1950-1965</td>
<td align="center">Investigated the effectiveness of the BCG vaccine at preventing TB disease when given at what as then school-leaving age. Followed the cohort over 15 years and estimated the effectiveness of the BCG vaccien in 2.5 year intervals from vaccination.</td>
<td align="center"><span class="citation">[@Hart1972]</span></td>
</tr>
<tr class="even">
<td align="center"><span class="math inline">\(\alpha_i^T\)</span></td>
<td align="center">Population based case-control study</td>
<td align="center">England</td>
<td align="center">2002-2014</td>
<td align="center">Recruited UK-born White subjects with TB and randomly smapled White community controls. Cox regression was used to adjusted for known confounders and the effectiveness of the BCG vaccine was estimated from 10 years after vaccination until 30 years after vaccinaton.</td>
<td align="center"><span class="citation">[@Mangtani2017]</span></td>
</tr>
<tr class="odd">
<td align="center"><span class="math inline">\(\delta\)</span></td>
<td align="center">Systematic review and meta-analysis</td>
<td align="center">Global</td>
<td align="center">Up to 2012</td>
<td align="center">Reviewed prospective cohort studies of persons exposed to individuals with infectious TB. Only included studies that were published before the widespread treatment of latent TB. Aimed to estimate the reduction in re-infection for latent TB cases.</td>
<td align="center"><span class="citation">[@Andrews2012]</span></td>
</tr>
<tr class="even">
<td align="center">
<span class="math inline">\(\beta_{\text{young-adult}}\)</span>, <span class="math inline">\(\gamma\)</span>, <span class="math inline">\(M_{\text{young-adult}}\)</span>, <span class="math inline">\(M\)</span>
</td>
<td align="center">-</td>
<td align="center">England</td>
<td align="center">-</td>
<td align="center">Where data, or literature, sources were not available assumed values were used based on expert opinion</td>
<td align="center">Assumption</td>
</tr>
</tbody>
</table>
</div>
<div id="scenarios" class="section level2">
<h2 class="hasAnchor">
<a href="#scenarios" class="anchor"></a>Scenarios</h2>
<table class="table">
<caption>
Summary of planned scenario analyses to be carried out in the next chapter as part of model fitting by comparision of the goodness of fit to the data.
</caption>
<thead><tr>
<th style="text-align:left;">
Parameter
</th>
<th style="text-align:left;">
Scenario
</th>
</tr></thead>
<tbody>
<tr>
<td style="text-align:left;width: 2cm; ">
<span class="math inline">\(\beta_a\)</span> - transmission probability
</td>
<td style="text-align:left;width: 12cm; ">
Constant across all age groups
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
</td>
<td style="text-align:left;width: 12cm; ">
Variable in young adults (15-29)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
<span class="math inline">\(M\)</span> - Non-UK born mixing
</td>
<td style="text-align:left;width: 12cm; ">
Constant across all age groups
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
</td>
<td style="text-align:left;width: 12cm; ">
Variable in young adults (15-29)
</td>
</tr>
</tbody>
</table>
</div>
  </div>

  <div class="col-md-3 hidden-xs hidden-sm" id="sidebar">
        <div id="tocnav">
      <h2 class="hasAnchor">
<a href="#tocnav" class="anchor"></a>Contents</h2>
      <ul class="nav nav-pills nav-stacked">
<li><a href="#disease-and-vaccination-parameters">Disease and vaccination parameters</a></li>
      <li><a href="#demographic-model-parameters">Demographic model parameters</a></li>
      <li><a href="#data-sources">Data sources</a></li>
      <li><a href="#scenarios">Scenarios</a></li>
      </ul>
</div>
      </div>

</div>


      <footer><div class="copyright">
  <p>Developed by Sam Abbott.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="https://pkgdown.r-lib.org/">pkgdown</a> 1.3.0.</p>
</div>
      </footer>
</div>

  

  </body>
</html>
